Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells.

Goepfert TM, McCarthy M, Kittrell FS, Stephens C, Ullrich RL, Brinkley BR, Medina D.

FASEB J. 2000 Nov;14(14):2221-9.


Hormone-induced chromosomal instability in p53-null mammary epithelium.

Pati D, Haddad BR, Haegele A, Thompson H, Kittrell FS, Shepard A, Montagna C, Zhang N, Ge G, Otta SK, McCarthy M, Ullrich RL, Medina D.

Cancer Res. 2004 Aug 15;64(16):5608-16.


Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability.

McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T, Dickson RB.

Oncogene. 1998 May 28;16(21):2755-66.


SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.

Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML, Graessmann A.

Oncogene. 1998 Apr 23;16(16):2103-14.


Brca2 deficiency does not impair mammary epithelium development but promotes mammary adenocarcinoma formation in p53(+/-) mutant mice.

Cheung AM, Elia A, Tsao MS, Done S, Wagner KU, Hennighausen L, Hakem R, Mak TW.

Cancer Res. 2004 Mar 15;64(6):1959-65.


A transgenic mouse model for mammary carcinogenesis.

Li B, Murphy KL, Laucirica R, Kittrell F, Medina D, Rosen JM.

Oncogene. 1998 Feb 26;16(8):997-1007.


Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells.

Liao WT, Lin P, Cheng TS, Yu HS, Chang LW.

Toxicol Appl Pharmacol. 2007 Dec 1;225(2):162-70. Epub 2007 Aug 8.


Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.

Katayose D, Gudas J, Nguyen H, Srivastava S, Cowan KH, Seth P.

Clin Cancer Res. 1995 Aug;1(8):889-97.


neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.

Li B, Rosen JM, McMenamin-Balano J, Muller WJ, Perkins AS.

Mol Cell Biol. 1997 Jun;17(6):3155-63.


Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.

Zelazny E, Li B, Anagnostopoulos AM, Coleman A, Perkins AS.

Exp Mol Pathol. 2001 Jun;70(3):183-93.


Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis.

Cheung AM, Hande MP, Jalali F, Tsao MS, Skinnider B, Hirao A, McPherson JP, Karaskova J, Suzuki A, Wakeham A, You-Ten A, Elia A, Squire J, Bristow R, Hakem R, Mak TW.

Cancer Res. 2002 Nov 1;62(21):6194-204.


The human papilloma virus 16E6 gene sensitizes human mammary epithelial cells to apoptosis induced by DNA damage.

Xu C, Meikrantz W, Schlegel R, Sager R.

Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7829-33.


Genomic instability and apoptosis are frequent in p53 deficient young mice.

Fukasawa K, Wiener F, Vande Woude GF, Mai S.

Oncogene. 1997 Sep;15(11):1295-302.


Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells.

Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D.

Nature. 2005 Oct 13;437(7061):1043-7.


Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis.

Seewaldt VL, Mrózek K, Dietze EC, Parker M, Caldwell LE.

Cancer Res. 2001 Jan 15;61(2):616-24.


Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development.

Li B, Greenberg N, Stephens LC, Meyn R, Medina D, Rosen JM.

Cell Growth Differ. 1994 Jul;5(7):711-21.


Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX.

Nat Genet. 1999 May;22(1):37-43.


Supplemental Content

Support Center